Welcome to our dedicated page for Cigna Group news (Ticker: CI), a resource for investors and traders seeking the latest updates and insights on Cigna Group stock.
The Cigna Group (NYSE: CI) news hub provides investors and healthcare professionals with timely updates on this global health services leader. Track official announcements, earnings reports, and strategic developments from Cigna's Evernorth Health Services pharmacy platform and Cigna Healthcare insurance division.
This page aggregates essential updates including regulatory filings, partnership announcements, and innovations in pharmacy benefit management. Stay informed about CI's initiatives in biosimilars adoption, digital health expansion, and value-based care models shaping the healthcare landscape.
Key coverage areas include quarterly financial results, Medicare Advantage updates, international market entries, and leadership changes. All content is sourced from verified corporate communications and reputable financial analysis to ensure reliability.
Bookmark this page for streamlined access to CI's latest developments affecting healthcare markets and investor decisions. Combine our news feed with SEC filings and earnings call transcripts for comprehensive research.
Accredo, a specialty pharmacy under Evernorth, Cigna's health services arm, has received URAC's Rare Disease Pharmacy Center of Excellence designation. This accreditation highlights Accredo's dedication to quality health services and improved outcomes for patients with rare diseases. With an estimated 25 to 30 million individuals affected by rare diseases in the U.S., Accredo's specialized resources include a team of about 500 pharmacists and 600 nurses, catering to 23 different rare diseases. URAC accreditation indicates excellence in patient care and safety.
Cigna Corporation reported total revenues of $174.1 billion in 2021, with a net income of $5.4 billion, or $15.73 per share. Adjusted income from operations was $7.0 billion, equating to $20.47 per share. For 2022, Cigna expects adjusted income from operations of at least $6.95 billion and a quarterly dividend increase of 12%, raising it to $1.12 per share. The company continues to experience strong customer growth, with total medical customers rising to 17.1 million.
Dr. Luis Torres, a behavioral health medical director at Cigna's health services business Evernorth, has been selected for a yearlong fellowship with CEO Action for Racial Equity. This initiative aims to tackle racial injustice through policy change at various levels. Cigna has supported health equity for over a decade, partnering with local organizations to enhance community well-being. Dr. Torres, with 20 years of experience in behavioral health, is committed to addressing disparities faced by his patients. Cigna remains dedicated to improving health outcomes and advancing equity.
Cigna Corporation (NYSE:CI) announced the appointment of Charles "Chuck" Berg as President of U.S. Government Business and Senior Advisor, effective January 31, 2022. Berg, a seasoned health care executive, aims to enhance Cigna's Medicare Advantage and Individual & Family Plan businesses. He will also join the Enterprise Leadership Team and report to CEO David Cordani. His previous roles include Executive Chair at DaVita Medical Group and CEO of Oxford Health Plans. Cigna anticipates significant growth in its government business under Berg's leadership, focusing on geographic expansion and improved product offerings.
Cigna Corporation (NYSE:CI) is set to release its fourth quarter 2021 financial results on February 3, 2022, with the conference call starting at 8:30 a.m. ET. The earnings announcement will be available by 6:30 a.m. ET and can be accessed on the company's Investor Relations website. Investors can participate by calling (888) 566-1253 for domestic or (773) 799-3825 for international calls, using passcode 232022. A replay will be available post-call until February 17, 2022.
Cigna Corporation (NYSE:CI) announced that CEO David Cordani will present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, via a virtual webcast. The presentation is set to begin at approximately 11:15 a.m. ET, and interested parties can access it through Cigna's investor relations page. With over 190 million customer relationships globally, Cigna focuses on improving health and well-being through integrated health services.
Cigna Corporation (NYSE:CI) announces Ralph Giacobbe as the new Senior Vice President and Head of Investor Relations, effective January 2022. Giacobbe, with over 20 years in the health care sector, brings a wealth of experience from Citigroup, where he led U.S. Health Care research. Cigna's CFO, Brian Evanko, expressed confidence in Giacobbe's ability to enhance the company's strategy and growth momentum. Giacobbe has a longstanding familiarity with Cigna, having covered the company for about a decade, and is poised to contribute significantly to the company's transformation efforts.
FAQ
What is the current stock price of Cigna Group (CI)?
What is the market cap of Cigna Group (CI)?
